In the latest quarter, 7 analysts provided ratings for Eli Lilly LLY +1.30% Get Free Report , showcasing a mix of bullish and ...

The drugmaker has become a clear winner with its weight-loss drugs. Now, with a pill under development, the company should see earnings gains through the end of the decade.

Eli Lilly reported impressive data at the recent American Diabetes Association ('ADA') conference. Its robust pipeline will ...

The Vital Role of Protein Synthesis in Modern Biotechnology and Its Impact on Chronic Disease Treatment, Technological Advances, and Market Growth" BOSTON ...

BCC Research announces the release of its "2024 Protein Synthesis Research Review," which provides comprehensive insights ...

The city's WNBA All-Star Host Committee has unveiled several Legacy Projects, aimed at improving the lives of Hoosier youth ...

The U.S. Food and Drug Administration approved changing the prescribing information for Eli Lilly's Alzheimer's drug Kisunla to allow more gradual dosing to lower the risk of a potentially dangerous ...

The FDA will allow a new dosing schedule for Eli Lilly’s Alzheimer’s drug Kisunla that could lessen a known side effect of ...

Stock indexes are mixed in midday trading Tuesday, coming off a broad sell-off following the Trump administration’s decision ...

Top 10 most valuable companies in 2025—see which global giants are leading the market with innovation, revenue, and impact.

Union momentum grows in Ireland’s €100bn pharma sector as Trump’s tariff threats and weak labour laws fuel worker unrest ...